SCHEMBL21450809

SCHEMBL21450809

C=C(C)OC(=C)c1ccc(C)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 3/20 0.35
▸ ADRA2A P08913 2/20 0.34
▸ ADRA2B P18089 2/20 0.34
▸ ADRA2C P18825 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CCR9 P51686 1/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA2 P54646 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAG3 Q9UGI9 1/20 0.32
▸ PRKAG2 Q9UGJ0 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ KCNQ3 O43525 1/20 0.32
▸ KCNQ2 O43526 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2659565 0.81 HDAC1 (0.52) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL123712 0.78 HDAC1 (0.52) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL7713081 0.78 DGAT1 (0.45) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL10659687 0.74 HDAC1 (0.53) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL9970923 0.74 ALDH1A1 (0.41) HDAC1HDAC6KMT2AMAPTALDH1A1
SCHEMBL8192122 0.74 HDAC1 (0.52) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL11625027 0.72 HDAC1 (0.50) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL17033581 0.72 HDAC1 (0.50) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL31290288 0.70 HDAC1 (0.62) HDAC1HDAC6KDM4EKMT2AMAPT
SCHEMBL575041 0.70 HDAC1 (0.62) HDAC1HDAC6KDM4EKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019194556-A1 NOVEL 6-HETEROARYLAMINO-2,4,5-TRIMETHYLPYRIDIN-3-OL COMPOUND, OR PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES AND AUTOIMMUNE DISEASES COMPRISING SAME 영남대학교 산학협력단 2019-10-10 — — WO disclosed
Send feedback